<DOC>
	<DOCNO>NCT00165815</DOCNO>
	<brief_summary>A randomised , double-blind , 3-arm parallel group study compare AriceptÂ® placebo .</brief_summary>
	<brief_title>The Efficacy , Tolerability Safety Donepezil ( Aricept ) Parkinson 's Disease Patients With Dementia</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Patients establish diagnosis PD dementia , fulfill inclusion criterion none exclusion criterion list , eligible enrolment study . Best effort must make clinical ground exclude patient DLB AD . The key inclusion criterion respect onset dementia document occur least 1 year diagnosis PD .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2005</verification_date>
</DOC>